Brain metastasis (BrM) is a major problem associated with cancer-related mortality, and
currently, no specific biomarkers are available in clinical settings for early detection. Liquid …

Glioblastoma multiforme (GBM) is one of the most lethal primary central nervous system
cancers with a median overall survival of only 12–15 months. The best documented …

Simple Summary Clinical management in neuro-oncology has shifted to an integrated
method that combines molecular profiles with histopathological and imaging data. Liquid …

Simple Summary Despite a substantial increase in publications in recent years, liquid biopsy
from blood, cerebrospinal fluid (CSF), and other body fluids is usually not routinely used in …

Brain cancers are among the top causes of death worldwide. Although, the survival rates
vary widely depending on the type of the tumor, early diagnosis could generally benefit in …

In recent years, liquid biopsy has emerged as an alternative method to diagnose and
monitor tumors. Compared to classical tissue biopsy procedures, liquid biopsy facilitates the …

Liquid biopsies collect and analyze tumor components in body fluids, and there is an
increasing interest in the investigation of liquid biopsies as a surrogate for tumor tissue in the …

Brain tumors include those that originate within the brain (primary tumors) as well as those
that arise from other cancers (metastatic tumors). The fragile nature of the brain poses a …

Tumour molecular profiling by liquid biopsy is being investigated for a wide range of
research and clinical purposes. The possibility of repeatedly interrogating the tumour profile …

Breast cancer continues to be a major global problem with significant mortality associated
with advanced stage and metastases at clinical presentation. However, several findings …